The Yorkville High Income MLP ETF (YMLP) pays investors a 9 percent dividend by using financial markets themselves to create income. An MLP (or master limited partnership) pays investors a handsome dividend created from 90 percent of its own revenues. In YMLP’s case, that revenue comes from tracking the performance (before fees and expenses) of the Solactive High Yield MLP Index. Because YMLP is an exchange-traded fund (ETF), it spreads its risk across a number of investments. With YMLP’s 9 percent dividend, market-focus and diversity, the fund gives investors income, while limiting risk.
Last week was mixed for U.S. stock markets, with the Dow Jones up 0.43% and the S&P 500 down 0.14%. The NASDAQ dropped 1.26%, while the MCSI Emerging Markets Index ended the week flat.
Big gainers in your Bull Market Alert portfolio included EOG Resources, Inc. (EOG), which added 5.38%; Visa Inc. (V), which rose 3.13%; and India's Tata Motors Limited (TTM), which gained 2.73%. Both EOG Resources, Inc. (EOG) and Tata Motors Limited (TTM) hit new 52-w
Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:
Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.
Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:
Exclusive Report: 3 Biotech Breakthroughs To Bank On
Where does the Smart Money look for the best biotech stocks? Small- and mid-cap biotechs. They're the ones with the ability to transform the world, and bring investors transformational profits. To get free access to Hilary Kramer's latest report, 3 Biotech Breakthroughs To Bank On, simply tell us where to send it in the box below.
*Along with my FREE report, Hilary Kramer's 3 Biotech Breakthroughs to Bank On, please also send Hilary's free weekly e-letter, Trading Desk. We value your privacy. You will not be spammed, ever. Period.